Profilo
Andrew Nebel is currently the Chairman at Duchenne UK.
He previously worked as the Director of Marketing and Communications at Barnardo's.
Posizioni attive di Andrew Nebel
| Società | Posizione | Inizio |
|---|---|---|
Duchenne UK
 Duchenne UK Investment Trusts/Mutual FundsMiscellaneous Duchenne UK is a UK-based charity that focuses on finding effective treatments for Duchenne muscular dystrophy (DMD), a progressive condition that weakens all the muscles in the body and is diagnosed in childhood. Additionally, Duchenne connects and supports families affected by DMD. The charity funds research that aims to provide treatments for those affected by DMD and removes roadblocks that prevent patients from accessing the treatments they need. The British company was founded in 2012 by Nick Crossley, Emily Crossley, and Alex Johnson, and Emily Crossley and Alex Johnson have been the CEOs since 2012. | Presidente | - |
Precedenti posizioni note di Andrew Nebel
| Società | Posizione | Fine |
|---|---|---|
Barnardo's
 Barnardo's Miscellaneous Commercial ServicesCommercial Services Barnardo's provides charitable services. The company was founded by Thomas John Barnardo in 1845 and is headquartered in Ilford, the United Kingdom. | Public Communications Contact | 01/07/2008 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Barnardo's
Barnardo's Miscellaneous Commercial ServicesCommercial Services Barnardo's provides charitable services. The company was founded by Thomas John Barnardo in 1845 and is headquartered in Ilford, the United Kingdom. | Commercial Services |
Duchenne UK
Duchenne UK Investment Trusts/Mutual FundsMiscellaneous Duchenne UK is a UK-based charity that focuses on finding effective treatments for Duchenne muscular dystrophy (DMD), a progressive condition that weakens all the muscles in the body and is diagnosed in childhood. Additionally, Duchenne connects and supports families affected by DMD. The charity funds research that aims to provide treatments for those affected by DMD and removes roadblocks that prevent patients from accessing the treatments they need. The British company was founded in 2012 by Nick Crossley, Emily Crossley, and Alex Johnson, and Emily Crossley and Alex Johnson have been the CEOs since 2012. | Miscellaneous |
- Borsa valori
- Insiders
- Andrew Nebel
